Global Cell Line Development Market forecast to reach $7.4bn by 2023

According to the research report, “Cell Line Development Market Size By Product [Reagents & Media, Equipment (Incubator, Centrifuge, Bioreactor, Microscope), Accessories & Consumables], By Source [Mammalian, Non-Mammalian (Insects, Amphibians)], By Cell Line [Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line], By Application [Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research] Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Competitive Market Share & Forecast, 2016 - 2023”, by Global Market Insights, Inc. says, Cell Line Development Market size will cross USD 7 billion by 2023; as per a new research report by Global Market Insights, Inc.

Advancement in methotrexate amplification (DHFR) technologies and glutamine synthetase (GS) technologies, growing demand for effective cancer treatment drive the growth of cell line development market in the coming years.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/429

Growing incidence rates of cancer and auto immune disorders that needs effective and early treatment are the main factors driving the cell line development market throughout the forecast timeframe. Moreover, favorable government initiatives for the development of healthcare infrastructure and the advancement of new technologies is likely to fuel the industry.

Reagents and media generated major revenue share in 2014. Increase in the demand of reagents and media for bioproduction from incubation to the cell line preservation are the factors driving the growth of the segment over the forecast timeframe.

The accessories and consumables segment is likely to grow at the fast rate over the forecast period due to increase in the usage rate of disposables for manufacturing vaccines and monoclonal antibodies. The mammalian source was the leading segment, owing to the high usage of mammalian cell line development techniques by many biopharmaceutical firms that are on the basis of methotrexate (MTX) amplification technology and glutamine synthetase (GS) system.

Browse key industry insights spread across 149 pages with 103 market data tables & 8 figures & charts from this 2017 report Cell Line Development Market in detail along with the table of contents at:

https://www.gminsights.com/industry-analysis/cell-line-development-market

Bioproduction is anticipated to contribute for the major revenue share in the application area of the cell line development market. Owing to the presence of technologically advanced processes for large scale production of biologics, increase in R&D activities and introduction of biosimilars and drive the growth of the segment in the coming years.

U.S. cell line development market led the North America segment. Increasing need for biologics, existence of enhanced healthcare infrastructure and growing awareness levels for cell therapy in the region are the important factors driving the growth of industry over the forecast period. China and India is expected to grow at a lucrative revenue share over the forecast timeframe. Owing to the presence of high untapped opportunities, supportive government initiatives and increased investments by manufacturers and government in biotechnology sector fuel the demand for cell line development market.

Based on source, mammalian cells represent the dominant segment for recombinant protein production, owing to their large volume to assemble proteins and add human-like post-translational modifications.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/429

Tissue engineering segment is expected to grow at a significant growth rate over the forecast timeframe. Rapid advancement in the stem cell research with a focus on their therapeutic potential for regenerative medicine and other biomedical applications drives the cell line development market growth.

Increasing prevalence of cancer with improved adoption of advanced technologies will drive U.S. cell line development market growth. Brazil is anticipated to grow at a significant growth rate due to booming biotechnology and pharmaceutical industry in the country.

Companies operating in cell line development market are American Type Culture Collection (ATCC), Selexis, GE Healthcare, Lonza Group, Sartorious, WuXi AppTec, Thermo Fisher Scientific, European Collection of Cell Cultures (ECACC), Corning and Sigma-Aldrich Corporation. Key players are focusing on offering wide range of product and collaborative agreement, to sustain their leadership position.

Browse Related Reports:

Tissue Engineering Market Size, Industry Analysis Report, Regional Outlook (U.S., Germany, UK, Italy, Russia, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, UAE, South Africa), Application Development, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/tissue-engineering-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web:https://www.gminsights.com
Blog:https://gminsights.wordpress.com

This release was published on openPR.